Chemical and Pharmaceutical Bulletin p. 1265 - 1273 (1998)
Update date:2022-07-31
Topics:
Suzuki, Tomoo
Usui, Toshinao
Oka, Mitsuru
Suzuki, Tsunemasa
Kataoka, Tadashi
In order to discover a medicine effective against Alzheimer's disease, we synthesized a series of quinoline derivatives having a characteristic 1- azabicyclo[3.3.0]octane amine ring, and performed pharmacological evaluation of them. Acetylcholine esterase inhibitory activities of these derivatives were unexpectedly weak. Tests for central nervous muscarinic cholinergic receptor binding affinity indicated that these compounds had higher affinities to muscarinic M1 receptors than to M2 receptors. A series of naphthalene derivatives substituted with the 1-azabicyclo[3.3.0]octane ring were also synthesized and muscarinic M1 and M2 receptor binding affinity determined. These compounds had much higher affinity for M1 receptors than the quinoline derivatives, and 1-[N-(1-azabicyclo[3.3.0]octan-5-yl)methyl-N- methylamino]-4-nitronaphthalene showed the highest affinity and selectivity. The ability of this compound to improve cognitive function was assessed using the passive avoidance test in scopolamine-induced mice.
View MoreHangZhou HuaYe Chemical Technology Co.,Ltd
Contact:+86-13505815007
Address:hangzhou
Shanghai ZaiQi Bio-Tech Co., Ltd.,
Contact:+86-21-6722 0633
Address:Bldg. No.7, No.201 MinYi Rd,Songjiang CaoHeJing High-Tech Park Shanghai 201516 P,R,China
xi'an taima biological engineering co., ltd.
Contact:+8615619038117
Address:6 No,keji road xi'an city of china
Ji'an Hairui Natural Plant Co. Ltd.
Contact:0796-8105528
Address:Meilin industry park, Qingyuan district Ji'an City, Jiangxi Province
AstaTech ( Chengdu) BioPharmaceutical Corp.
website:http://www.astabiochem.cn/
Contact:+86-15680585308
Address:SICHUAN CHENGDU
Doi:10.1016/j.bmc.2014.02.008
(2014)Doi:10.1016/j.orgel.2017.04.025
(2017)Doi:10.1016/j.cclet.2014.01.005
(2014)Doi:10.1039/P29860001331
(1986)Doi:10.1016/S0040-4020(01)87601-8
(1986)Doi:10.1055/s-2008-1078487
(2008)